Activation of c-Jun NH2-terminal kinase and subsequent CPP32/Yama during topoisomerase inhibitor β-lapachone-induced apoptosis through an oxidation-dependent pathway

Cancer Research

Volumn 59, Issue 2, 1999, Pages 391-398

  Shiah, Shine Gwo ^a   Chuang, Shuang En ^b   Chau, Yat Pang ^c   Shen, Shing Chuan ^a   Kuo, Min Liang ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; ASCORBIC ACID; BETA LAPACHONE; CAMPTOTHECIN; DNA TOPOISOMERASE INHIBITOR; ETOPOSIDE; HYDROGEN PEROXIDE; MITOGEN ACTIVATED PROTEIN KINASE; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL STRAIN HL 60; CONTROLLED STUDY; DRUG ACTIVITY; DRUG ANTAGONISM; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; OXIDATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

APOPTOSIS; CASPASE 3; CASPASES; DNA TOPOISOMERASES, TYPE I; ENZYME ACTIVATION; ENZYME INHIBITORS; HELA CELLS; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE KINASE 4; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NAPHTHOQUINONES; PROTEIN KINASES; REACTIVE OXYGEN SPECIES;

EID: 0033556233     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Schaffner-Sabba, K., Schmidt-Ruppin, K. H., Wehril, W., Schuerch, A. R., and Wasley, J. W. F. β-Lapachone. Synthesis of derivatives and activates in tumor models. J. Med. Chem., 27: 990-994, 1984.
2. Guiraud, P., Steiman, R., Campos-Takaki, G. M., Seigle-Mrandi, F., and Simeon de Buochberg, M. Comparison of antibacterial and antifungal activities of lapachone and β-lapachone. Planta Med., 60: 373-374, 1994.
3. Lopes, J. N., Cruz, F. S., Docampo, R., Vasconcellos, M. E., Sampaio, M. C., Pinto, A. V., and Gilbert, B. In vitro and in vivo evaluation of the toxicity of 1,4-naphthoquinone and 1,2-naphthoquinone derivatives against Trypanosoma cruzi. Ann. Trop. Med. Parasitol., 72: 523-531, 1978.
4. Goijman, S. G., and Stoppani, A. O. Effects of β-lapachone, a peroxide-generating quinone, on macromolecule synthesis and degradation in Trypanosoma cruzi. Arch. Biochem. Biophys., 240: 273-281, 1985.
5. Schuerch, A. R., and Wehrli, W. β-Lapachone, an inhibitor of oncornavirus reverse transcriptase and eukaryotic DNA polymerase-α: inhibitory effect, thiol dependence and specificity. Eur. J. Biochem., 84: 197-205, 1978.
6. Li, C. J., Zhang, L. J., Dezube, B. J., Crumpacker, C. S., and Pardee, A. B. Three inhibitors of type I human immunodeficiency virus long terminal repeat-directed gene expression and virus replication. Proc. Natl. Acad. Sci. USA, 90: 1839-1842, 1993.
7. Boorstein, R. J., and Pardee, A B. β-Lapachone greatly enhances MMS lethality to human fibroblasts. Biochem. Biophys. Res. Commun., 118: 828-834, 1984.
8. Boothman, D. A., Greer, S., and Pardee, A. B. Potentiation of halogenated pyrimidine radiosensitizers in human carcinoma cells by β-lapachone (3,4-dihydro-2,2-dimethyl-2H-naphthol[1,2-b]pyran-5,6-dione), a novel DNA repair inhibitor. Cancer Res., 47: 5361-5366, 1987.
9. Li, C. J., Averboukh, L., and Pardee, A. B. β-Lapachone: a novel DNA topoisomerase I inhibitor with a mode of action different from camptothecin. J. Biol. Chem., 268: 22463-22468, 1993.
10. Frydman, B., Marion, L. J., Sun, J. S., Neder, K., Witiak, D. T., Liu, A. A., Wang, H. M., Mao, Y., Wu, H. Y., Sanders, M. M., and Liu, L. F. Induction of DNA topoisomerase II-mediated DNA cleavage by β-lapachone and related naphthoquinones. Cancer Res., 57: 620-627, 1997.
11. Planchon, S. M., Wuerzberger, S., Frydman, B., Witiak, D. T.. Hutson, P., Church, D. R., Wilding, G., and Bootman, D. A. β-Lapachone-mediated apoplosis in human promyelocytic leukemias (HL-60) and human prostate cancer cells: a p53-independent response. Cancer Res., 55: 3706-3711, 1995.
12. Li, C. J., Wang, C., and Pardee, A. B. Induction of apoptosis by β-lapachone in human prostate cancer cells. Cancer Res., 55: 3712-3715, 1995.
13. Chau, Y-P., Shiah, S-G., Don, M-J., and Kuo, M-L. Involvement of hydrogen peroxide in topoisomerase inhibitor β-lapachone-induced apoptosis and differentiation in human leukemia cells. Free Radical Biol. Med., 24: 660-670, 1998.
14. Avruch, J., Zhang, X. F., and Kyriakis, J. M. Raf meets Ras: completing the framework of a signal transduction pathway. Trends Biochem. Sci., 19: 279-283, 1994.
15. Sachsenmaier, C., Radler-Pohl, A., Zinck, R.. Nordheim, A., Herrlich, P., and Rahmsdorf, H. J. Involvement of growth factor receptors in the mammalian UVC response. Cell. 78: 963-972, 1994.
16. Chen, Y.-R., Wang, X., Templeton, D., Davis, R. J., and Tan, T-H. J. The role of c-jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and γ radical. Duration of JNK activation may determine cell death and proliferation. J. Biol. Chem., 271: 31929-31936, 1996.
17. Derijard, B., Hibi, M., Wu, I-H., Barrett, T., Su, B., Deng, T., Karin, M., and Davis, R. JNK1:a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-jun activation domain. Cell, 76: 1025-1037, 1994.
18. Liu, Z. G., Hsu, H.. Goeddel, D. V.. and Karin. M. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell, 87: 565-576, 1996.
19. Mosser, D. D., Caron, A. W., Bourget, L., Denis-Larose, C., and Massie, B. Role of the human heat shock protein hsp70 in protection against stress-induced apoptosis. Mol. Cell. Biol., 17: 5317-5327, 1997.
20. Kyriakis, J. M., Banerjee, P., Nikolakaki, E., Dai, T., Rubie, E. A., Ahmad, M. F., Avruch, J., and Woodgett, J. R. The stress-activated protein kinase subfamily of c-jun kinases. Nature (Lond.), 369: 156-160, 1994.
21. Hibi, M., Lin, A., Smeal, T., Minden, A., and Karin, M. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-jun activation domain. Genes Dev., 7: 2135-3148, 1993.
22. Verheij, M., Bose, R., Lin, X. H., Yao, B., Jarvis, W. D., Grant, S., Birrer, M. J., Szabo, E., Zon, L. I., Kyriakis, J. M., Haimovitz-Friedman, A. Fuks, Z., and Kolesnick, R. N. Requirement for ceramide-initiated SAPK/JNK signaling in stress-induced apoptosis. Nature (Lond.), 380: 75-79, 1996.
23. Rosette, C., and Karin, M. Ultraviolet light and osmotic stress: activation of the JNK cascade through multiple growth factor and cytokine receptor. Science (Washington DC), 274: 1194-1197, 1996.
24. Paris, M., Ensoli, B., Stahl, N., Yancopoulos, G., Nguyen, A., Wang, S., and Nel, A. E. Differential activation of the extracellular signal-regulated kinase. Jun kinase and Janus kinase-Stat pathways by oncostatin M and basic fibroblast growth factor in AIDS-derived Kaposis sarcoma cells. AIDS, 10: 369-378, 1996.
25. Paris, M., Kokot, N., Lee, L., and Nel, A. E. Regulation of interleukin-2 transcription by inducible stable expression of dominant negative and dominant active mitogen-activated protein kinase kinase kinase in Jurkat T cells. J. Biol. Chem., 271: 27366-27373, 1996.
26. 2-terminal protein kinase pathway in the cellular response to Adriamycin and other chemotherapeutic drugs. J. Biol. Chem., 271: 30950-30955, 1996.
27. 2-terminal kinase-mediated activation of interleukin-1 β converting enzyme/CED-3-like protease during anticancer drug-induced apoptosis. J. Biol. Chem., 272: 4631-4636, 1997.
28. Chinnaiyan, A. M., and Dixit, V. M. The cell-death machine. Curr. Biol., 6: 555-562, 1996.
29. Henkart, P. A. ICE family proteases: mediators of all apoptotic cell death? Immunity, 4: 195-201, 1996.
30. Enari, M., Hug, H., and Nagata, S. Involvement of an ICE-like proteases in Fas-mediated apoptosis. Nature (Lond.), 375: 78-81, 1995.
31. L antagonize the mitochondrial dysfunction proceeding nuclear apoptosis induced by chemotherapeutic agents. Cancer Res., 57: 62-67, 1997.
32. Guyton, K. Z., Gorospe, M., Kensler, T. W., and Holbrook, N. J. Mitogen-activated protein kinase (MAPK) activation by butylated hydroxytoluene hydroperoxide: implication for cellular survival and tumor promotion. Cancer Res., 56: 3480-3485, 1996.
33. Hu, Z. B., Yang, G. S., Li, M., Miyamoto, N., Minden, M. D., and McCulloch, E. A. Mechanism of 1-β-D-arabinofuranosylcytosine toxicily to the blast cells of acute myeloblastic leukemia: involvement of free radical. Leukemia (Baltimore), 9: 789-798, 1995.
34. Slater, A. F., Nobel, C. S., Maellaro, E., Bustamante, J., Kimland, M., and Orrenius, S. Nitrone spin traps and a nitroxide antioxidant inhibit a common pathway of thymocyte apoptosis. Biochem J., 306: 771-778, 1995.
35. Docampo, R., Cruz, N. S., Boveris, A., Muniz, R. P. A., and Esquivel, D. M. S β-Lapachone enhancement of lipid peroxidation and superoxide anion and hydrogen peroxide formation by sarcoma 180 ascites tumor cells. Biochem. Pharmacol., 20: 723-728, 1979.
36. Misra, H. P., and Fridovich, I. The univalent reduction of oxygen by reduced flavins and quinones. J. Biol. Chem., 247: 188-192, 1972.
37. Xia, Z., Dickens, M., Raingeaud, J., David, R., and Greenberg, M. E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science (Washington DC), 270: 1326-1331, 1995.
38. 2-terminal kinase. J. Biol. Chem., 272: 15920-15927, 1997.
39. Yan, M. Activation of stress-activated protein kinase by MEKK phosphorylaticn of its activation SEK1. Nature (Lond.), 372: 798-800, 1994.
40. 2-terminal kinases. J. Biol Chem., 271: 15703-15707, 1996.
41. 2-terminal kinase-mediated activation of interleukin-1 β converting enzyme/CED-3-like protease during anticancer drug-induced apoptosis. J. Biol. Chem., 272: 4631-4636, 1997.
42. Lee, S. Y., Reichlin, A., Santana, A., Sokol, K. A., and Nussenzweig, M. C. TRAF2 is essential for JNK but not NF-κB activation and regulates lymphocyte proliferation and survival. Immunity, 7: 703-713, 1997.
43. Gravestein, L. A., Amsen, D., Boes, M., Calvo, C. R., Kruisbeek, A. M. K., and Borst, J. The TNF receptor family member CD27 signals to Jun N-terminal kinase via Traf-2. Eur. J. Immunol., 28: 2208-2216, 1998.
44. Kumar, S., and Harvey, N. L. Role of multiple cellular proteases in the executicn of programmed cell death. FEBS Lett., 375: 169-173, 1995.
45. Cardone, M. H., Salvesen, G. S., Widmann, C., Johnson, G., and Frisch, S. M. The regulation of anoikis: MEKK1 activation requires cleavage by caspases. Cell, 90: 315-323, 1997.
46. Davis, R. J. The mitogen-activated protein kinase signal transduction pathway. J. Biol. Chem., 268: 14553-14556, 1993.